Consistent with our results, other studies have reported that FGF-1 significantly increases AMPK phosphorylation, preventing nonalcoholic fatty liver disease [47] and diabetic cardiomyopathy [45] in mice. The gene discussed is FGF1; the disease is metabolic dysfunction-associated steatotic liver disease.